Perfromance Wealth Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Sell
23,104
-2,020
-8% -$141K 0.04% 73
2025
Q4
$1.67M Sell
25,124
-1,793
-7% -$116K 0.05% 63
2025
Q3
$1.81M Sell
26,917
-1,709
-6% -$135K 0.05% 52
2025
Q2
$2.5M Sell
28,626
-6,370
-18% -$499K 0.08% 45
2025
Q1
$2.39M Hold
34,996
0.09% 42
2024
Q4
$2.72M Buy
34,996
+1,420
+4% +$105K 0.09% 37
2024
Q3
$2.25M Sell
33,576
-570
-2% -$46.8K 0.08% 42
2024
Q2
$3.87M Hold
34,146
0.14% 27
2024
Q1
$4.74M Sell
34,146
-2,941
-8% -$370K 0.2% 34
2023
Q4
$4.6M Sell
37,087
-2,664
-7% -$272K 0.2% 39
2023
Q3
$3.71M Sell
39,751
-900
-2% -$101K 0.18% 47
2023
Q2
$5.21M Buy
40,651
+680
+2% +$82.2K 0.24% 34
2023
Q1
$4.64M Buy
39,971
+14,483
+57% +$1.62M 0.24% 36
2022
Q4
$2.89M Buy
25,488
+1,500
+6% +$165K 0.17% 42
2022
Q3
$1.93M Sell
23,988
-880
-4% -$74.5K 0.11% 47
2022
Q2
$1.85M Buy
24,868
+80
+0.3% +$7.3K 0.1% 50
2022
Q1
$3.17M Hold
24,788
0.14% 43
2021
Q4
$3.33M Buy
+24,788
New +$3.56M 0.13% 48

Other funds holding DXCM

Perfromance Wealth Partners's DXCM Position: Q1 2026 in Review

Perfromance Wealth Partners reduced its DexCom (DXCM) stake by 8% in Q1 2026, selling an estimated $141K and leaving 23,104 shares worth $1.45M. The position accounts for 0.04% of the portfolio, ranked #73.

Perfromance Wealth Partners first reported a position in DXCM in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.21M in Q2 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Perfromance Wealth Partners held 23,104 shares of DexCom worth $1.45M as of Q1 2026.
  • Perfromance Wealth Partners sold 2,020 DexCom shares in Q1 2026, an estimated $141K.
  • DexCom made up 0.04% of Perfromance Wealth Partners's portfolio in Q1 2026, its #73 holding.
  • Perfromance Wealth Partners first reported a position in DexCom in Q4 2021 and has held it in 18 quarters since.
  • Perfromance Wealth Partners's DexCom position peaked at $5.21M in Q2 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.